308 related articles for article (PubMed ID: 26475480)
1. Pharma Success in Product DevelopmentâDoes Biotechnology Change the Paradigm in Product Development and Attrition.
Evens RP
AAPS J; 2016 Jan; 18(1):281-5. PubMed ID: 26475480
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
3. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
4. Lasofoxifene: CP 336156, CP-336156.
Drugs R D; 2005; 6(1):56-60. PubMed ID: 15801869
[TBL] [Abstract][Full Text] [Related]
5. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
8. Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016.
McNamee LM; Cleary EG; Zhang S; Salim U; Ledley FD
Clin Ther; 2021 Jan; 43(1):156-171.e15. PubMed ID: 33380363
[TBL] [Abstract][Full Text] [Related]
9. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
Evens RP; Kaitin KI
Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
[TBL] [Abstract][Full Text] [Related]
10. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
[TBL] [Abstract][Full Text] [Related]
11. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
12. The rise (and decline?) of biotechnology.
Kinch MS
Drug Discov Today; 2014 Nov; 19(11):1686-1690. PubMed ID: 24747562
[TBL] [Abstract][Full Text] [Related]
13. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
[TBL] [Abstract][Full Text] [Related]
14. Target product selection - where can Molecular Pharming make the difference?
Paul MJ; Teh AY; Twyman RM; Ma JK
Curr Pharm Des; 2013; 19(31):5478-85. PubMed ID: 23394563
[TBL] [Abstract][Full Text] [Related]
15. Biotechnology financing, not acquisitions, for filling the pharma pipeline - a sustaining strategy.
Fernandes P
Expert Opin Drug Discov; 2007 Jul; 2(7):917-21. PubMed ID: 23484812
[TBL] [Abstract][Full Text] [Related]
16. Biotech acquisitions by big pharma: why and what is next.
Malik NN
Drug Discov Today; 2009 Sep; 14(17-18):818-21. PubMed ID: 19584004
[TBL] [Abstract][Full Text] [Related]
17. Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
Drugs R D; 2008; 9(3):191-6. PubMed ID: 18457472
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
19. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
20. Small biotechs versus large pharma: Who drives first-in-class innovation in oncology?
Kennedy KH; Gomez K; Thovmasian NJ; Chang DC
Drug Discov Today; 2023 Feb; 28(2):103456. PubMed ID: 36403884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
